微信关注
China
Total item
Cart Subtotal
￥ 0.00 “sb269970 hcl”的搜索结果
34 个项目
每页
-
Ractopamine HCl
Catalog No. A17372 beta-Adrenergic agonistRactopamine HCl is a beta-Adrenergic agonist. It acts by being a full agonist at the TAAR1. 了解更多 -
Pardoprunox HCl (SLV-308)
Catalog No. A11538 Pardoprunox HCl (SLV-308)是一种抗帕金森病药物，是多巴胺受体D2、D3和5-HT1A激动剂，用于治疗帕金森病。 了解更多 -
Dexmedetomidine HCl
Catalog No. A11846 alpha2-adrenoceptor 激动剂Dexmedetomidine hydrochloride是美托咪啶的活性异构体，它充当有效的，高度选择性的α2-AR（α2-肾上腺素受体）激动剂。 了解更多 -
Methoxamine HCl
Catalog No. A17365 alpha-1 adrenergic agonistMethoxamine Hydrochloride is an alpha-1 adrenergic agonist that causes prolonged peripheral vasoconstriction. 了解更多 -
Medetomidine HCl
Catalog No. A13775 adrenergic alpha-2 receptor 激动剂Medetomidine Hydrochloride是一种肾上腺素α2-受体激动剂，Ki为1.08 nM，比作用于α1-adrenoceptor选择性高1620倍。由于其镇痛和镇静作用而被用于兽医学。 了解更多 -
Ivabradine HCl (Procoralan)
Catalog No. A11868 Ivabradine Hydrochloride,也称为S-16257，是缓动剂伊伐布雷定的盐酸盐制剂。 了解更多 -
Adrenalone HCl
Catalog No. A11807 -
Nebivolol HCl
Catalog No. A10630 Nebivolol hydrochloride是β1-肾上腺素受体的高度选择性拮抗剂（Ki = 0.88 nM，β2-肾上腺素受体Ki = 48 nM）。 了解更多 -
Alfuzosin HCl
Catalog No. A10052 Alfuzosin HCl是用于治疗良性前列腺增生（BPH）的α1受体拮抗剂。 它通过放松前列腺和膀胱颈的肌肉来起作用，使其更容易排尿。 了解更多 -
Nifenalol HCl
Catalog No. A17246 beta-adrenergic receptor antagonistNifenalol, also known as INPEA, is a new beta-adrenergic receptor antagonist. 了解更多 -
Clorprenaline HCl
Catalog No. A16465 -
Acebutolol HCl
Catalog No. A16387 -
S(-)-Propranolol HCl
Catalog No. A13428 β-adrenergic blockerS(-)-Propranolol HCl是一种非选择性的β-肾上腺素能受体（βAR）拮抗剂，对β1AR和β2AR具有高亲和力，Ki值分别为1.8 nM和0.8 nM。 盐酸普萘洛尔抑制[3H] -DHA与大鼠脑膜制剂的结合，IC50为12 nM。 了解更多 -
Phentolamine HCl
Catalog No. A13421 -
Celiprolol HCl
Catalog No. A13623 adrenergic receptor 拮抗剂Celiprolol HCl是一种b1肾上腺素能受体拮抗剂和b2肾上腺素能受体局部激动剂，在体外显示其ED50值为40-50 uM可使人的动脉和静脉松弛。 了解更多 -
Atipamezole HCl
Catalog No. A13902 α2 adrenergic receptor 拮抗剂Atipamezole hydrochloride是一种选择性α2肾上腺素受体拮抗剂（α2A、α2B、α2C、α1A和α1B受体的Ki值分别为1.1、1.0、0.89、1300和6500nm）。已经被证明是大脑的渗透剂。 了解更多 -
Bambuterol HCl
Catalog No. A14251 -
Labetalol HCl
Catalog No. A14239 alpha1/beta adrenergic receptors 拮抗剂Labetalol HCl是选择性α1-肾上腺素能受体和非选择性β-肾上腺素能受体的双重拮抗剂。 了解更多 -
Isoprenaline HCl
Catalog No. A10484 β adrenoceptor 激动剂Isoprenaline HCl或isoproterenol是非选择性β肾上腺素能激动剂，在结构上类似于肾上腺素。 了解更多 -
Naftopidil 2HCl
Catalog No. A10619 5-HT1A and α1-adrenergic receptor 拮抗剂Naftopidil 2HCl是选择性5-HT1A和α1-肾上腺素能受体拮抗剂，IC50分别为0.1μM和0.2μM。 了解更多 -
Metipranolol hydrochloride
Catalog No. A18064 β-adrenergic receptor antagonistMetipranolol (hydrochloride) is a non-selective β-adrenergic receptor (β-AR) antagonist. Formulations containing metipranolol have been used in the treatment of elevated IOP in patients with ocular hypertension or glaucoma. 了解更多 -
Moxisylyte hydrochloride
Catalog No. A17725 alpha-adrenergic blocking agentMoxisylyte hydrochloride is an alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. 了解更多 -
Asenapine HCl
Catalog No. A15002 adrenergic receptor/5-HT receptor 抑制剂Asenapine hydrochloride抑制肾上腺素能受体（α1，α2A，α2B，α2C）的Ki为0.25-1.2 nM，还抑制5-HT受体（1A，1B，2A，2B，2C，5A，6、7），Ki为0.03- 4.0 nM。 了解更多 -
Xylazine HCl
Catalog No. A13434 -
Octopamine hydrochloride
Catalog No. A13419 Octopamine hydrochloride是一种无脊椎生物胺神经递质，与去甲肾上腺素相关，是肾上腺素受体激动剂。 了解更多 -
Tetrahydrozoline Hydrochloride
Catalog No. A13080 -
Oxymetazoline hydrochloride
Catalog No. A10686 -
Phenoxybenzamine hydrochloride
Catalog No. A10719 α-adrenergic (AR) 拮抗剂/CaM 抑制剂Phenoxybenzamine hydrochloride是一种细胞可渗透的，非特异性的，不可逆的α-肾上腺素（AR）拮抗剂，也可作为CaM抑制剂。 了解更多 -
Phenylephrine HCl
Catalog No. A11666 α1-adrenergic receptor 激动剂Phenylephrine HCl是一种选择性的α1肾上腺素能受体激动剂，主要用作减充血剂，扩张瞳孔和增加血压的药物。 了解更多
34 个项目
每页
联系我们
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
Not your Region? View all Distributors
FILTER BY:
Filtering:
- 分类: Adrenergic Receptors 删除该内容
购物选项
- 作用机制
-
- Inhibitor (抑制剂) (2)
- Agonist (激动剂) (12)
- Antagonist (拮抗剂) (11)
- Blocker (阻断剂) (3)
ADOOQ 产品质量保证
We promise all products to perform as described.